Spondyloarthritis & psoriatic arthritis

Arrhythmic risk stratification in psoriatic arthritis: a retrospective, electrogram-based comparative analysis

RMD OpenPublished Retrospective cohort study

Authors' conclusion

Patients with PsA are at a significantly increased risk for ECG abnormalities related to both atrial and ventricular repolarisation as well as atrioventricular conduction.

Study context

Population
Patients with psoriatic arthritis (PsA) presenting to one centre 2014–2022 and age- and sex-matched cardiovascular patients (mean age 52.5±13.4 years)matched cohort
Participants
725 vs 725
Exposure
PsA vs matched cardiovascular patients
  • PsAn = 725
  • Controlsn = 725reference
Methodological detailsage-matched and sex-matched controls, single-centre, electrogram-based comparative analysis, Median PsA duration 2 years
  • Age-matched and sex-matched controls
  • Single-centre
  • Electrogram-based comparative analysis
  • Median PsA duration 2 years

Further findings

First-degree AV block (AVB I°)

P = 0.725

Significant P-wave terminal force in V1 (excluding known atrial arrhythmias)

P < 0.001

OutcomePsAControlsP value
Corrected Tpeak-Tend interval0.26 ± 0.040.23 ± 0.05P < 0.001
AVB I° within PsA by sex (age-adjusted)Male vs Female · after adjusting for ageP = 0.006
AVB I° within PsA by disease duration (age-adjusted)Long disease duration vs Shorter disease duration · after adjusting for ageP < 0.001
  • AVB I° within PsA by sex (age-adjusted): Male 16.4%
  • AVB I° within PsA by sex (age-adjusted): Female 7.1%
  • AVB I° within PsA by disease duration (age-adjusted): Long disease duration 18.0%
  • AVB I° within PsA by disease duration (age-adjusted): Shorter disease duration 6.9%

Original publication

Arrhythmic risk stratification in psoriatic arthritis: a retrospective, electrogram-based comparative analysis. RMD Open. Published 24 June 2026. doi:10.1136/rmdopen-2026-007006

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.